---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-24-000083"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:44:24.433166+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics shareholders elect directors, ratify auditor, approve share issuance

## Summary
- Three Class I directors elected: Robert Connelly (6,248,397 for), Katie Chudnovsky (6,233,264), Allen Nissenson (6,249,739).
- Ratification of Baker Tilly US, LLP as auditor for FY2024: 7,434,248 for, 1,188 against, 17,558 abstain.
- Approved issuance of shares upon exercise of warrants and convertible note per Nasdaq Rule 5635(b): 6,269,593 for, 81,508 against.
- Quorum of 7,452,994 shares voted (69.17% of voting power); all proposals passed.

## SEC filing metadata
- accession: 0001601485-24-000083
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000083/0001601485-24-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000083/angn-20241121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-24-000083
- JSON: https://secwatch.observer/filing/0001601485-24-000083.json
- Plain text: https://secwatch.observer/filing/0001601485-24-000083.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.